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ABSTRACT 
Somatic cell nuclear transfer (SCNT) has wide application in transgenesis, conservation of 
biodiversity, generation of patient-specific autologous stem cells and biomedical engineering. 
This technology, however, could not be exploited to its full potential due to the nuclear 
reprogramming errors and high incidence of phenotypic abnormalities and perinatal deaths in 
SCNT clones. Although investigations on these deaths, chiefly peri-natal and early post-natal, 
hypothesize aberrant epigenetic programming as the underlying cause, no confirmatory studies 
are available. Many reports on the deaths have pointed out abnormalities in cardiovascular 
system in the cloned species.  This work aimed at comparative protein expression of heart tissues 
obtained from three piglet samples, namely those born out of normal conception (NC), the live 
SCNT clones (CL) and the dead SCNT clones (CD). Global protein profiling data from these 
three sample sets were obtained from high-throughput proteomic approach of LC-MS/MS and 
differentially expressed proteins were analyzed. The protein expression data were annotated and 
analyzed using data mining approaches, and a pattern in proteins showing abnormal expression 
was hypothesized. Analysis revealed that most of the proteins involved in basal metabolism were 
down-regulated in the cloned species. This may cause aberrant metabolism, leading to death. A 
number of proteins pertaining to signaling pathways involved in heart formation were also found 
to be either down-regulated or the expression level was undetectable in cloned samples. Thus, it 
could be hypothesized that incomplete or aberrant signaling processes could affect the formation 
of the heart and therefore, result in peri-natal deaths. Structural proteins of the heart, and proteins 
involved in heart function were also differentially expressed, pointing at loss of structural 
integrity and/or functional competency of the heart resulting in early deaths. Taken together, this 
study revealed that heart of SCNT clones was both developmentally and functionally insufficient 
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with gross abnormalities of basal metabolism. Further studies should validate these data to 
decipher novel ways to circumvent these issues and improve the efficiency of the SCNT 
technology. 
Key Words: SCNT, proteomics, LC-MS/MS, data mining, KDD, DAVID, mass spectrometry. 
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INTRODUCTION 
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Somatic cell nuclear transfer (SCNT) technology has been a major breakthrough in biomedical 
engineering for the derivation of patient-specific stem cells, transgenesis, conservation of 
biodiversity and animal cloning [1, 2]. The technology has been widely used for rapid propagation 
of genetically superior animals, resurrection of endangered species, production of 
pharmaceutically important proteins and preservation of germplasm through somatic cell 
banking. In humans, SCNT has been used to evaluate the development potential of gamete and 
embryos. Another major application of SCNT is the study of reprogramming events occurring 
during cell differentiation [3, 4]. However, despite successful production of healthy clones in a 
number of species, including mice, sheep, cattle, goats, pigs, rabbits, cats and dogs, the 
efficiency of the process has been very low due to incomplete or aberrant nuclear reprogramming 
[5,6]. Even though SCNT embryos are capable of normal embryonic development machinery, yet 
they have much lower rates of development, ultimately leading to embryonic and foetal deaths [7, 
8]. Furthermore, clones occasionally show phenotypic abnormalities and high incidence of 
perinatal and early post-natal deaths accompanied with gestational abnormalities such as 
placental anomalies, large offspring syndrome and anomalies of umbilical cord [9, 10, 11]. In 
particular, organs of cardiovascular and respiratory systems commonly show incomplete 
organogenesis and functional inefficiency [12]. Despite numerous speculations, hypotheses and 
analytical research, the underlying causes of these abnormalities and deaths are, however, largely 
unknown. 
Proteomic studies deal with large-scale analysis of all proteins expressed in a biological system 
in a given space and time [13]. It can not only provide qualitative and quantitative information of 
the global protein expression, but also allows the detailed analysis of complex biological network 
of interconnected signaling pathways in different biological phenomena. The ultimate goal of 
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proteomics is to create a complete three-dimensional map of cells in a system, indicating protein 
location, functions and interactions. Large-scale global protein profiling through various high-
throughput techniques has also enabled the simultaneous evaluation of multiple proteins in 
SCNT clones and has been useful in divulging the aberrancy during embryonic and fetal growth. 
Application of mass spectrometry (MS) methods such as matrix-assisted laser 
desorption/ionization time-of-flight (MALDI-TOF) and MS/MS combined with multi-
dimensional liquid chromatography (LC-MS/MS) and gel-based fluorescence two-dimensional 
differential gel electrophoresis (2D-DIGE) methods on cellular lysate of SCNT clones have 
revealed the role of mitochondrial protein levels in developmental losses [14], and the role of 
spindle composition and formation [15], placental dysfunction [16], etc. in developmental 
abnormalities. However, a large scale sequencing, identification and expression analysis of 
global proteins in heart tissue of SCNT clones has not been investigated. Furthermore, most 
studies have utilized MALDI-TOF or gel-based proteomic approaches which suffer from certain 
shortcomings. While in MALDI-TOF, the relationship between the amount of analyte present 
and measured signal intensity is complex and therefore, signal intensity of a peptide ion does not 
directly indicate the absolute amount of protein present and it can be used to identify relatively 
simple peptide mixtures [17], gel-based proteomics remain a low throughput approach that 
requires a relatively large amount of sample. LC-MS/MS allows sequencing of complex peptide 
samples and enables multi-dimensional protein identification. However, data on LC-MS/MS 
analysis of heart tissue are scarce. 
A requirement of large scale proteomic approaches is to analyze, annotate and mine the 
voluminous data to decipher the useful information. Data mining refers to the process of 
exploration and analysis by computational or semi-computational means of large data sets with 
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an aim to determine or predict implicit, previously unknown potentially useful correlations or 
discover some hidden pattern or trend in the existing data, without any a priori knowledge of the 
biological interpretation of the data. Although data mining is one of the major steps of 
Knowledge Discovery in Databases (KDD), the two terms are often used interchangeably. Data 
mining involves various forms of interpretation and information harvesting, including predictive 
classification, descriptive clustering and cluster analysis, deviation/ anomaly detection, 
predictive regression, sequential pattern discovery and association rule discovery.  The objective 
of data mining is to classify large amounts of data and form corresponding hypotheses in order to 
be able to build a predictive model of the underlying biological process to reduce the need for 
experimentation. The application of data mining techniques is now being extended to the 
prediction of protein interactions and protein modifications, including their dynamics, in addition 
to the conventional study of protein interaction, abundance and activation.  
This study was designed for the data mining and bioinformatics analysis of protein expression 
data experimentally obtained by reverse phase LC-MS/MS combined with 1-D SDS-PAGE. The 
protein profiling was obtained from the heart of three sample sets, namely live piglets born out of 
normal conception, live SCNT piglets and dead SCNT piglets. The objective of the study was to 
compare the global protein profiling and examine the pattern, if any, among the differentially 
expressed proteins to draw a plausible explanation for early peri-natal death of SCNT clones. 
Various data mining approaches were followed to attain the aforementioned objective.  
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2.1  Foetal abnormalities in SCNT clones 
SCNT technology has unveiled the capabilities of an oocyte to reprogram the somatic genome 
from a differentiated to a totipotent state. After the first successful cloning of the sheep Dolly by 
Dr. Ian Wilmut in 1996, the technique has been successfully replicated in several species, 
including mice, sheep, cattle, goats, pigs, rabbits, cats and dogs [18-24].  However, the success rate 
of producing healthy, live animals through the process of cloning across various animal species 
is less than 5% [24-26], owing to the incomplete and/or aberrant nuclear programming in SCNT. 
Specifically, pig oocytes are highly sensitive to stressors and chemical factors associated with 
nuclear transfer technology. Studies show that the lipids in pig oocytes affect embryonic 
development following SCNT [27]. Numerous instances of perinatal and early post-natal deaths 
observed in majority of SCNT cloning cases [28-30] have restricted the exploration of this 
technique for various applications, and specifically for reproductive cloning purposes. Many 
accounts of incomplete organogenesis and functional inefficiency have been reported in various 
organs, primarily in the organs of cardiovascular and respiratory systems [12]. The deaths have 
been majorly attributed to foetal and embryonic abnormalities, including large offspring 
syndrome, low birth weight and abnormal gestation length [11, 31, 32]. Many of the surviving 
clones succumb to a number of other abnormalities potentially arising out of inappropriate or 
incomplete epigenetic reprogramming, resulting in a plethora of abnormalities, such as 
malformed organs, weakened immune system, internal hemorrhaging, metabolic abnormalities, 
cardiopulmonary abnormality, lymphoid hypoplasia, behavioral abnormalities, neonatal 
respiratory distress and multiple organ failure [12, 33]. Studies have shown that the low efficiency 
of the SCNT process could be due to aberrant and/or incomplete epigenetic reprogramming, 
including post-translational modifications like DNA methylation and histone modification [34-36]. 
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Epigenetic reprogramming consists of different processes like genomic imprinting [37], X-
chromosome inactivation [38] and gene silencing [39, 40]. It also encompasses embryonic [41-43] and 
placental [44-46] development, carcinogenesis [47-49] and reprogramming in SCNT embryos [36, 50]. 
Faulty epigenetic patterns are found to vary in a species-specific and cell type-specific manner 
[51]. Morphological modification of the donor nucleus by the recipient cell is essential for 
successful nuclear reprogramming, that leads to transcriptional silencing, removal of epigenetic 
marks and appropriate gene expression [52]. However, in SCNT embryos, reversal of epigenetic 
modifications needs to occur before the zygotic genome activation [53], which usually remains 
incomplete and/or aberrant. Aberrant DNA methylation does not follow a defined pattern, and is 
species-specific. While in pig embryos, increasing DNA methylation is observed from the one-
cell stage to the blastocyst stage [54, 55], limited demethylation has been observed in sheep, with 
no remethylation [56]. Aberrant histone modification is much more complex, and hence no 
general pattern has been established. Incomplete remodeling of H4K8ac and H4K12ac has been 
observed in the somatic nucleus after SCNT [57]. Some aberrant histone methylation patterns 
have also been observed [58]. Transcription in cloned animals is affected by the relationship 
between these two epigenetic abnormalities [59, 60]. Study of epigenetic reprogramming errors 
associated with SCNT is of particular importance since reprogramming events in the induced 
pluripotent stem (iPS) cells follows a similar pattern to that of SCNT clones. Hence, this 
information may have application in the iPS cell research.  
2.2 Proteomics 
Proteomic approach has been gaining increasing importance in the scientific world since it 
generates huge amounts of data that, on proper analysis, could provide massive information and 
multi-faceted interpretation that could be extended to a detailed understanding of the working of 
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the living system, including problems associated with it and developing potential solutions to 
those problems. This field has come a long way from large-scale separation and identification of 
proteins to all possible kinds of analyses of protein sets as well as the interactions among them 
[17]. Proteomics can broadly be classified into three major divisions, namely clinical proteomics, 
structural proteomics and functional proteomics. Clinical proteomics deals with the investigation 
of disease biomarkers. Structural proteomics deals with the analysis and understanding of 
cellular proteins. Functional proteomics deals with the investigation of cell signaling 
mechanisms. Until recently, two-dimensional polyacrylamide gel electrophoresis (2-DE) was 
primarily used for proteomic profiling of cellular systems [61, 62]. This approach involved 
solubilization of the entire protein content of a system and their subsequent separation on 2D 
gels. 2-DE, though most preferable, is associated with major limitations in the profiling of 
proteins with very low or high molecular masses, low abundance, extreme pI or high 
hydrophobicity [63, 64]. Advances in large scale global protein profiling include 2D-DIGE, MS, 
protein microarray, in silico proteomics and activity-based profiling. The 2D-DIGE involves the 
mixing of two pools of proteins labeled with different fluorescent dyes, and separation in the 
same gel. On the other hand, MS approach derives information on the basis of mass-to-charge 
(m/z) ratio of the proteins. This technique involves fractionation of protein samples by 1D SDS-
PAGE or 2-DE, digestion of the proteins into peptides by sequence-specific proteases such as 
trypsin, followed by separation of the peptides by HPLC or ion-exchange chromatography. 
Subsequently, ionization of the sample is done by electrospray ionization (ESI) or MALDI. 
Finally, mass analysis is done by one of the mass analyzers viz. Quadrupole or TOF or ion trap 
Fourier Transform ion-cyclotron (FT-MS) mass analyzer. MALDI-TOF is commonly used to 
identify proteins by peptide-mass fingerprinting. Further advancements in high-throughput 
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technologies have introduced the technique of surface-enhanced laser desorption/ionization time-
of-flight mass spectrometry (SELDI-TOF MS) [65 - 67]. This approach has enabled the proteomic 
expression profiling of single human embryos [68] and of proteins secreted during in vitro culture 
of human and mouse embryos [69]. Currently preferred multi-dimensional protein profiling 
technology is LC-MS/MS [70, 71]. Further advances introduce LC-MS/MS with tandem mass tags 
[72], isotope-coded affinity tags (ICAT) [73] or isobaric tag for relative and absolute quantification 
(iTRAQ) [74, 75]. Alternatively, technology combining one-dimensional (1-D) protein separation 
with reverse phase LC-MS/MS is also used [76].  
The proteomic approach has also been used for the discovery of novel biomarkers for the 
diagnosis of diseases, prediction of susceptibility, monitoring disease progression, therapeutic 
targeting and patient-tailored therapy [77-79]. In addition, it has many other promising 
applications, including establishment of protein-protein interactions, determination of post-
translational modifications by phosphoproteomics and glycoproteomics [80, 81] and identification 
and designing of potential drugs. Proteomic approach has been increasingly used for the study of 
various diseases and their corresponding drug discovery studies [82], including different types of 
cancer [83], kidney-related diseases [84], cardiovascular diseases like myocardial infarction and 
neural diseases like Alzheimer’s disease [85] and multiple sclerosis [86].  
MS methods such as MALDI-TOF and LC-MS/MS, and gel-based 2D-DIGE methods have been 
widely used to analyze cellular lysates of SCNT clones in order to investigate the foetal 
abnormalities. 2D-DIGE has been used to study the variations in mitochondrial protein levels 
between control, SCNT-derived and artificial insemination-derived cattle to analyze the 
mitochondrial-related gene expression in developmental losses of SCNT embryos [14]. Proteomic 
analyses have also been conducted on spindles isolated from normal oocytes and SCNT-derived 
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oocytes in metaphase II stage in order to associate low term developmental potential of SCNT 
embryos with deficiencies in spindle composition and assembly [15].  2-DE has been used for the 
comparative proteomic analysis of malformed umbilical cords in SCNT-derived piglets [87]. A 
global proteomic approach using 2-DE and MS has been used to analyze differential protein 
profiling of different placentae samples to determine the role of placental dysfunction as a cause 
of post-natal death [9]. 2DE and MALDI-TOF MS have also been used for the proteomic analysis 
of extra-embryonic tissues from cloned porcine embryos [88]. In other experiments, MALDI-TOF 
MS peptide mass fingerprinting and MALDI-TOF MS/MS peptide sequence analysis have been 
used to examine the differential abundance of bovine conceptus fluid proteins [89].  
2.3 Data Mining 
The huge amount of data generated by current proteomic approaches demands for efficient and 
robust computational tools to successfully mine the data and accurately extract meaningful 
information. KDD is basically an iterative process, consisting of seven basic steps [90] (Figure 1). 
The first step is Data Cleaning, wherein noise and irrelevant data is removed from the data set. 
The second step is Data Integration, in which the data set is analyzed across multiple data 
sources or databases combined in a common source. This step is followed by Data Selection, in 
which relevant data is shortlisted and retrieved separately. The next step is Data Transformation, 
otherwise known as data consolidation, in which the selected data is transformed into different 
forms that are friendly to the subsequent mining procedure. The fifth step is Data Mining, which 
is the most relevant and crucial step of the entire KDD process. This process involves the 
recognition or discovery of hidden patterns in the given data set in order to deduce meaningful 
hypotheses or models. This step is followed by Pattern Evaluation, in which interesting and 
plausible patterns corresponding to the given requirements are identified. The last step in the 
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KDD process is Data Representation, which deals with the visual and/or graphical representation 
of the acquired information for better understanding and further analysis. One or more of these 
steps may be consolidated, suiting various requirements. There are various approaches to data 
mining, depending on the source and procedure of obtaining the data, and the kind of 
interpretation required. It specifically depends on the data type, i.e. whether the data to be 
analyzed is a sequence data, structure data, spectroscopic data or image data. Data mining may 
either be descriptive or predictive, each determining the kind of pattern that can be discovered. 
The criticality of the discovered patterns depends on the validity when tested on new data, degree 
of certainty, understandability, novelty and usefulness of the patterns. 
 
Figure 1: Strategy for data mining of proteomic data 
Constant progress is seen in this direction, with a steady increase in the number and kind of 
databases to accommodate the data and the development of superior tools for efficient mining of 
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the data. Some examples of such tools developed over the past decade include Database for 
Annotation, Visualization and Integrated Discovery (DAVID), MAPPFinder, GeneMerge, etc. [91 
- 93]. Data mining is currently used for a majority of proteomic assessment studies and subsequent 
applications like validating the role of certain proteins or groups of proteins in diseases [94], 
identification of biomarkers [78, 79, 95], mapping of regulatory mechanisms pertaining to 
physiological processes [96], identification of drug targets and drug delivery approaches [82], etc. 
Certain visual mining tools directly make use of information generated by high-throughput 
sequencing and proteomics based on mass spectrometry. Some examples of such tools are 
mspecLINE, CircAtlas and Cytoscape [97, 98]. Proteomic analysis of a single system or 
comparative analyses between two systems, differing on one or more defined parameters, use 
bioinformatics and data mining approach. For example, comparative proteomic analysis of 
parthenogenetically developed and in-vitro fertilized embryo [99], comparison between nuclear 
reprogramming via transcription factors and during SCNT [100], etc. The interactive exploration 
and linking of complementary proteomic and structural data is highly focused on, and is 
facilitated by a very less number of bioinformatics tools. Two of such tools that are widely used 
for complementary study purposes are STRING and structureViz [101].  
2.4 Bioinformatics Tools for Data Mining 
Data mining involves the use of various general-purpose and bioinformatics tools, as well as 
high-level languages. Three of the most common programming languages used are Structured 
Query Language (SQL), Practical Extraction and Report Language (PERL) and Python. All three 
of these are interpreted scripting languages, and hence slow in execution. PERL and Python are 
flexible and powerful languages for mining of sequence and textual data, while SQL is useful 
only for querying a relational database and isn’t a stand-alone application. However, it has the 
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advantages of high performance, portability between databases and vendor-independence. A 
large number of general-purpose web-based as well as stand-alone data mining applications are 
also available, including Angoss, Clustran, Daisy, DataMind, Miner, Magnify, MatLab, Oracle 
Darwin, Spotfire, etc. Some of these applications are database-specific (e.g. Oracle Darwin), 
while others are non-specific and can be used with any database system (e.g. SAS). MatLab is a 
widely used commercial application that can be extended through add-ons. Bioinformatics-
specific tools include Multiple Em for Motif Elicitation (MEME), Pattern-Induced Multi-
sequence Alignment (PIMA), Pratt and Sequence Pattern EXhaustive Search (SPEXS). MEME 
is used for motif discovery. PIMA is used for multiple sequence alignment of a sequence set. 
Pratt is used as a pattern discovery tool in a set of unaligned protein sequences. SPEXS is used 
for discovery of sequence patterns.  
An integrated biological knowledgebase and a set of analytical tools for functional annotation of 
genomic or proteomic information is available in DAVID [91, 102]. This platform was developed 
by the National Institute of Allergy and Infection Disease (NIAID), National Institute of Health 
(NIH) for the enhancement of data analysis in functional annotation, especially for microarray 
and proteomic studies. The algorithm and tools of DAVID provide a high-throughput data 
mining environment for systematic extraction of biological meaning from large input datasets 
[ref] by means of batch annotations and gene ontology (GO) term enrichment analysis. It 
provides extensive annotation coverage over nearly 40 annotation categories containing one or 
more databases, including disease databases like OMIM, Gene Ontology, functional databases 
like PIR, COG, etc., pathway databases like KEGG, BIOCARTA, etc., literature databases like 
PUBMED, etc., as well as other databases for protein domains, protein interactions and tissue 
expression. The tools permit the selection of GO parameters for clustering of proteins based on 
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their cellular localization, molecular function and involvement in biological processes. Cellular 
component pertains to the sub-cellular or extra-cellular location of the protein, or a gene product 
group that it might be a part of. The domain of molecular function explores the elemental 
activities of the protein at the molecular level. Biological process, on the other hand, defines the 
function of the protein in terms of a series of events involving one or more molecular functions 
with a defined beginning and end. DAVID displays results in three formats, namely, as cluster, 
chart and table. Gene enrichment is determined by Expression Analysis Systematic Explorer 
(EASE) score, which uses Fisher Exact test. In addition to function annotation, DAVID also 
provides much other functionality like functional classification of genes, gene ID conversion into 
various formats and also a batch viewer of gene names. The result of analysis is represented in 
three forms, namely cluster, chart and table. Functional analysis clustering report is a non-
redundant representation of the data, clustered using the integrated techniques of Kappa 
statistics, used to measure the degree of similarity between two annotations, and fuzzy heuristic 
clustering, used for classification based on kappa values. It offers various filtering parameters, 
namely stringency ranging from lowest to highest, similarity term overlap, similarity threshold, 
initial group membership, final group membership and multiple linkage thresholds. Functional 
annotation chart is a listing of annotation terms with their associated genes. It uses EASE score 
threshold, which represents a modified Fisher Exact p-value that ranges from 0 to 1 (0 
representing perfect enrichment). A p-value of 0.05 or lower is considered to be a strong 
enrichment value. Functional annotation table is a gene-centric view that involves non-statistical 
listing of genes and their associated annotation terms. 
Cytoscape is yet another open source software platform that facilitates the analysis and 
visualization of complex network data and biological pathways, and integration of this data with 
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various kinds of annotations and gene expression profiles. It is widely considered a standard tool 
for integrated analysis and visualization of networks in biological research [103]. Cytoscape 
organizes data in terms of network graphs, with biological entities depicted as nodes, and the 
interactions between them depicted as edges. Attribute values help in mapping of nodes and 
edges to specific values, and are used to control their visual aspects and perform network 
searches. This tool has a total of 66 built-in functions. Cytoscape provides a common platform 
for the analysis of diverse types of data against multiple public databases at a time, including 
Reactome, String, Uniprot, ChEMBL, DIP, etc. It also has the provision of merging the output 
data for a set of input data from different databases into one network in order to facilitate easy 
analysis of inter-connections between the networks. Cytoscape is widely used for visualization 
and analysis of biological networks [104], visualization of protein interaction networks [105], 
computational construction of specialized biological networks [106], construction of 
computational network models for various visualization of biological phenomena [107], 
visualization of multi-dimensional cancer genomics data [108] and integration of genomic and 
proteomic information with biological networks [109].  
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3.1 Discovery Proteomics 
Heart tissue samples from piglets were kindly donated by Dr. Sang Jun Uhm, Konkuk 
University, South Korea. The tissues were collected from the live piglets born out of normal 
conception (n = 3) or SCNT (n = 3) and from the dead piglets created by SCNT (n = 3). Proteins 
were extracted from each sample, separated on 1D-SDS PAGE, digested by trypsin, purified by 
column chromatography using C18 reversed phase resin and analyzed by reverse phase LC-nano 
ESI-MS/MS using LTQ ion-trap mass spectrometer essentially as described previously [99] and 
was performed at the Institute of Biomedical Science and Technology, South Korea. The 
acquired MS/MS spectra were searched against the non-redundant National Center for 
Biotechnology Information (NCBI) protein database for mammalian and Sus scrofa proteins in 
both forward and reverse in order to strike a compromise between minimizing the number of 
false positives and avoiding missing real protein hits [110]. Mammalian database was searched 
because protein database of S. scrofa is still incomplete. 
Three data sets were analyzed, one comprising of protein expression profile of piglets born out of 
normal conception, hereafter referred to as NC1 for mammalian and NC2 for S. scrofa, another 
comprising of protein expression profile of live piglets created by SCNT, hereafter referred to as 
CL1 for mammalian and CL2 for S. scrofa, and the last comprising of protein expression profile 
of dead piglets created by SCNT, hereafter referred to as CD1 for mammalian and CD2 for S. 
scrofa. A dataset for the proteins that were differentially expressed across different categories 
(normal conception, cloned live and cloned dead) was also compiled, hereafter referred to as 
DE1 for mammalian and DE2 for S. scrofa.  
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3.2 Data Mining (DM) / Knowledge Discovery in Database (KDD) 
Following filtering techniques were used for removing the noisy and irrelevant data from the 
data sets. On matching with the NCBI database, only those protein sequences were considered 
that had a match of at least two peptides with the database. The rest of the data was neglected. In 
addition, data was cleansed based on the intensity of the spectra obtained from mass 
spectrometry results. The sequences were mined both in forward and reverse directions, and a 
true match was considered only if the false positive rate, defined as the number of unique 
peptides identified from the reversed database search (number of false positives) divided by the 
number of unique peptides identified from the normal database search number of true positives 
plus the number of false positives) [111], was less than 0.05. In case of multiple protein database 
entries for the same set of peptides, only a single entry (highest molecular weight) was 
considered. Quantification of the proteomic data was done by measuring peak heights and 
peptide counts. The protein abundance was estimated by considering the coverage of unique 
peptides as well as the total number of repeat observations of peptides.  
The identified proteins were annotated by the functional annotation tool suite of the DAVID 
Bioinformatics Resources version 6.7 (URL: http://david.abcc.ncifcrf.gov). Three major gene 
ontology parameters viz. cellular component, molecular function and biological process [112] 
were analyzed and proteomic data from all the three datasets were clustered using different 
stringency parameters. The resulting patterns were manually evaluated and refined to finally 
determine following stringency parameters: Multiple mammalian species were selected as the 
background, including Homo sapiens, Sus scrofa, Bos taurus, Canis lupus, Rattus norvegicus, 
Mus musculus and Macaca mulatta. Medium stringency was used for the classification process. 
Kappa similarity search was used with a similarity term overlap value of 3, and similarity 
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threshold of 0.50. For the classification, both initial and final group membership values were 
taken as 3, with a multiple linkage threshold of 0.50. Expression Analysis Systematic Explorer 
(EASE) was used for enrichment with a threshold value of 1.0. 
Based on the information obtained from the analysis of the proteomic data, hypotheses were 
formed as to the nature of the proteins affected in cloned piglets that result in the SCNT 
abnormalities. Hypothesis testing was performed using the bioinformatics tool Cytoscape version 
3.0.1 (URL: http://www.cytoscape.org). Five databases, namely Reactome, GeneMANIA, 
IntAct, String and UniProt were searched. Reactome (URL: 
http://www.reactome.org/ReactomeGWT/entrypoint .html) is an open-source manually curated 
pathway database.  IntAct (URL: http://www.ebi.ac.uk/intact/) is an open-source database 
system and tools for analysis of molecular interaction data. String (URL: http://string-db.org/) is 
a database of known and predicted protein associations, including both physical and functional 
associations. UniProt (URL: http://www.uniprot.org/ is an open-source database of protein 
sequence and functional information.  
3.3 Data Validation 
Expression level of selected 13 genes that were found to be differentially expressed among the 
three sample types viz. NC, CD and CL, were validated by reverse transcriptase polymerase 
chain reaction (RT-PCR) of total RNA isolated from the respective samples. The validation was 
performed by Bio-Organ Research Center, South Korea using the procedure described earlier 
[113]. 
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4.1 Protein Profiling of Heart 
4.1.1  Heart proteins in piglets 
Analysis of these peptide sequences, generative from LC-MS/MS spectra, against non-redundant 
NCBI protein database led to the identification of 507 mammalian proteins and 447 S. scrofa 
proteins with confidence level of 95%. The number of proteins identified in each dataset, i.e. NC, 
CL and CD for both mammalian and S. scrofa proteins is given in Table 1.  
Table 1: Total number of proteins identified in each dataset, i.e. NC, CL and CD for mammalian 
and S. scrofa proteins 
Normal Conception (NC) SCNT Cloned Live (CL) SCNT Cloned Dead (CD) 
NC1 
 
155 
NC2 
 
203 
CL1 
 
135 
CL2 
 
14 
CD1 
 
70 
CD2 
 
90 
DB: non-redundant NCBI database 
 
Numerical classification of the differentially expressed proteins in heart samples of cloned 
piglets according to the number of unique peptides matching each identified protein is given in 
Table 2.  
Among these proteins, 26 mammalian proteins and 44 S. scrofa proteins had sequence coverage 
of > 30%. The distribution of proteins according to their sequence coverage is shown in Figure 2. 
The twenty most abundant proteins in cloned embryos identified by LC-MS/MS are presented in 
Table 3. 
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Table 2:  Number of differentially expressed proteins of heart samples from piglets classified 
according to the number of unique peptides matching each identified protein 
No. of 
unique 
peptides 
matching 
per 
protein 
Normal Piglet Cloned Piglet born Live Cloned Piglet born Dead 
Mammalian 
DB 
S. scrofa DB 
Mammalian 
DB 
S. scrofa DB 
Mammalian 
DB 
S. scrofa DB 
0 10 1 15 99 77 19 
2~4 75 67 78 34 50 78 
5~9 46 40 40 3 15 28 
>10 16 32 14 4 5 15 
Total 147 140 147 140 147 140 
a) Acceptance Spectrum Mill score > 11; scored peak intensity >60%; confidence level  > 95%. 
b) DB : non-redundant NCBI database 
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Figure 2: Pie charts depicting the sequence coverage of mammalian (A) and S. scrofa (B) 
proteins identified by LC-MS/MS 
 
Further analysis of the data revealed that among the identified 507 mammalian proteins,  only 45 
overlapped between the three datasets, whereas in case of 447 S. scrofa proteins, 21 proteins 
overlapped. In case of mammalian datasets, out of 507 proteins, the number of proteins uniquely 
expressed in NC1, CL1 and CD1 were 55, 135 and 71 respectively. In case of porcine datasets, 
out of 447 proteins, the number of proteins uniquely expressed in NC2, CL2 and CD2 were 201, 
14 and 91 respectively. Comparison of fold changes in the levels of identified proteins revealed 
that 147 mammalian and 140 S. scrofa proteins were differentially expressed, corresponding to 
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29% and 31% of the total proteins respectively. This indicates a similarity between the data from 
mammalian and S. scrofa databases. 
Table 3:  Twenty most abundant proteins in heart of cloned piglets identified by LC-MS/MS 
Protein Percent 
coverage 
Number of 
unique peptides 
Number of 
total peptides 
Desmin  41.8 14 43 
Malate dehydrogenase  18.0 4 23 
Histone 1 12.4 2 18 
Annexin A2  20.1 6 13 
Calsequestrin 8.3 4 10 
Synaptopodin 2 8.2 3 10 
Phosphoglycerate kinase 1 23.5 7 9 
SERPINA3-6  27.1 6 9 
Troponin I  19.4 3 9 
Pyruvate dehydrogenase 14.9 5 8 
Spectrin 6.1 7 7 
Talin 1 4.9 6 7 
Clathrin  4.2 5 7 
Cadherin 2 11.6 4 7 
Elongation factor 1 - alpha 2 20.3 4 7 
Ubiquinol cytochrome C reductase 10.2 2 7 
Apoptosis-inducing factor 15.2 6 6 
Calcium/calmodulin-dependent protein kinase  13.2 4 6 
RAS oncogene family isoform 3 31.8 4 6 
Myomesin 2 3.8 4 6 
Peptide sequences were matched with S. scrofa protein sequences in nrNCBI database 
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MS methods such as MALDI-TOF and LC-MS/MS, and gel-based 2D-DIGE methods have been 
widely used to analyze cellular lysates of SCNT clones in order to investigate the foetal 
abnormalities. One such study analyzed spindle composition and assembly in SCNT clones to 
elucidate the role of spindles in decreased developmental potential of SCNT embryos [15]. A 
global proteomic approach using 2-DE and MS has been used to analyze differential protein 
profiling of different placentae samples to determine the role of placental dysfunction as a cause 
of post-natal death [9]. However, a large scale sequencing, identification and expression analysis 
of global proteins in heart tissue on SCNT clones has not yet been investigated. In addition, 
MALDI-TOF or gel-based proteomic approaches used for most of the studies suffer from certain 
shortcomings, restricting the global profiling of tissue samples. This study was the first record of 
global protein profiling of heart samples. It applied reverse phase LC-nano ESI-MS/MS 
combined with 1-D SDS-PAGE strategy for peptide sequencing in heart samples of piglets born 
out of SCNT technology. No other report of using LC-MS/MS for global proteomic analysis has 
been found. 
4.1.2  Normal versus cloned piglets 
Among the differentially expressed mammalian proteins, 52 proteins were up-regulated in cloned 
piglets as compared to normal piglets, out of which 15 were up-regulated by two or more folds.  
54 proteins were down-regulated in cloned piglets as compared to normal piglets, out of which 
20 were down-regulated by two or more folds. 15 proteins were unique to the normal samples, 
with undetected expression levels in cloned samples. On the other hand, 10 proteins were unique 
to the cloned samples, with undetected expression levels in normal samples.  
In S. scrofa, only two proteins were up-regulated in cloned piglets as compared to normal piglets 
by less than two-fold. 37 proteins were down-regulated in cloned piglets as compared to normal 
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piglets, out of which 33 were down-regulated by two or more folds. 19 of the proteins were 
down-regulated by five-fold or more. 99 proteins were unique to the normal samples, with 
undetected expression levels in cloned samples. On the other hand, only one protein was unique 
to the cloned samples, with undetected expression levels in normal samples. 
The number of up-regulated and down-regulated proteins corresponding to the fold changes in 
heart samples from cloned piglets in comparison to normal piglets is shown in Table 4. 
Differential expression of proteins in normal and SCNT clones have been studied to identify the 
proteins that could be responsible for the abnormalities and deaths in SCNT clones.  Variations 
in mitochondrial protein levels have been analyzed between control and SCNT clones using 2D-
DIGE [14]. 2-DE has also been used for the comparative proteomic analysis  of malformed 
umbilical cords in normal and SCNT-derived piglets. A limited number of proteins were 
considered for this study. Another approach was the use of 2-DE and MALDI-TOF for 
proteomic analysis of extra-embryonic tissue from cloned porcine embryos [88]. However, the 
gel-based proteomics require very large amounts of samples, and are low throughput 
technologies.  
4.1.3  Live versus Dead cloned piglets 
Among the differentially expressed mammalian proteins, 52 proteins were up-regulated in CD1 
as compared to CL1, out of which 15 were up-regulated by two or more folds.  26 proteins were 
down-regulated in CD1 as compared to CL1, out of which 20 were down-regulated by two or 
more folds. 77 proteins were unique to CL1 and had undetected expression levels in CD1 On the 
other hand, 15 proteins were unique to CD1 with undetected expression levels in CL1. 
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In S. scrofa, 19 proteins were up-regulated in CD2 as compared to CL2, out of which 12 were 
up-regulated by two or more folds. Three proteins were down-regulated in CD2 as compared to 
CL2, within a range of 15 to 3 folds. 99 proteins were unique to the CD2, with undetected 
expression levels in CL2. On the other hand, 19 proteins were unique to the CL2, with 
undetected expression levels in CD2. 
The number of up-regulated and down-regulated proteins corresponding to the fold changes in 
heart samples from cloned dead piglets in comparison to cloned live piglets is shown in Table 5. 
Majority of the studies have compared the protein profiles of normally born animals with those 
developed by SCNT. Not much work has been done on the comparative proteomic analysis 
between live and dead SCNT clones.  
Table 4: Number of proteins up- or down-regulated in heart samples from cloned piglets in 
comparison to normal piglets as revealed by reverse phase LC-MS/MS 
Fold change 
Mammalian DB S. scrofa DB 
Up-regulated Down-regulated Up-regulated Down-regulated 
<2 41 39 2 5 
2~5 11 14 0 16 
5~10 0 1 0 14 
>10 0 0 0 3 
Total 52 54 2 38 
DB: non-redundant NCBI database 
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Table 5: Number of proteins up- or down-regulated in heart samples from cloned dead piglets in 
comparison to cloned live piglets as revealed by reverse phase LC-MS/MS 
Fold change 
Mammalian DB S. scrofa DB 
Up-regulated Down-regulated Up-regulated Down-regulated 
< 2 15 16 7 2 
2~5 0 17 9 1 
5~10 0 2 0 0 
>10 0 1 0 0 
Total 15 36 16 3 
DB: non-redundant NCBI database 
 
4.2 Functional annotation and cellular location 
4.2.1  Heart proteins in cloned piglets 
The LC-MS/MS analysis could identify both cellular and membrane proteins. The distribution of 
the identified proteins across different cellular locations in mammalian and S. scrofa is shown in 
Figure 3.  
To further analyze the probable cellular processes and signaling pathways that might be 
disrupted in cloned piglets compared to normal piglets, the differentially expressed proteins 
between the two groups were assigned functional annotations in order to cluster them into groups 
in accordance with their biological and molecular functions. The analysis revealed that binding 
activity and catalytic activity were the main functions of a majority of the differentially 
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expressed proteins. The differentially expressed proteins were majorly involved in basal 
metabolism, including glycolysis and tricarboxylic acid cycle (44% in mammalian and 43% in S. 
scrofa). A classification of the differentially expressed proteins across major biological processes 
is given in Figure 4. 
A 
 
 
Figure 3: Pie charts depicting the distribution of mammalian (A) and S. scrofa (B) proteins 
across different cellular components 
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Figure 4: Pie charts depicting the classification of differentially expressed mammalian (A) and 
S. scrofa (B) proteins on basis of biological process involved 
 
4.2.2  Normal versus cloned piglets 
Among the 60 annotated mammalian proteins that were up-regulated in cloned piglets as 
compared to normal piglets, majority of the proteins (30.9%) were involved in specific molecular 
functions related to basal metabolism, including glycolysis and tricarboxylic acid (TCA) cycle. 
Among the 50 annotated mammalian proteins that were down-regulated in cloned piglets as 
compared to normal piglets, 25.7% were involved in molecular functions related to basal 
metabolism. Other proteins had structural activity, ion binding activity, transporter activity, 
nucleotide binding activity and other enzyme activities. A classification of the up-regulated and 
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down-regulated proteins on basis of molecular functions in cloned piglets as compared to normal 
piglets is shown in Figure 5. 
 
 
Figure 5: Pie charts depicting the functional classification on basis of molecular function of 
proteins up-regulated (A) and down-regulated (B) in cloned piglets as compared to normal 
piglets. 
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4.2.3  Live versus Dead cloned piglets 
Among the 15 annotated mammalian proteins that were up-regulated in cloned dead piglets as 
compared to cloned live piglets, 20.7% were involved in specific molecular functions related to 
basal metabolism, including glycolysis and TCA acid cycle. Among the 36 annotated 
mammalian proteins that were down-regulated in cloned dead piglets as compared to cloned live 
piglets, 25% were involved in molecular functions related to basal metabolism. Other proteins 
had structural activity, ion binding activity, transporter activity, nucleotide binding activity and 
other enzyme activities. A classification of the up-regulated and down-regulated proteins on 
basis of molecular functions in cloned piglets as compared to normal piglets is shown in Figure 
6. 
4.3 Proteins related to basal metabolism 
We found at least 22 differentially expressed proteins in mammalian and 19 in S. scrofa that are 
known to be related to basal metabolism, including the processes of glycolysis, TCA cycle, 
glucose metabolism, glycogen metabolism and gluconeogenesis. This included almost all 
enzymes of glycolysis and TCA cycle, and some enzymes of the other metabolic processes. The 
affected proteins and their corresponding role in glycolysis and TCA cycle are depicted in 
Figures 7 and 8 respectively. All proteins of glycolysis, and most of the proteins of TCA cycle 
were down-regulated. These cycles are crucial for basic cell survival. Hence, basal metabolism 
could be targeted in cloned species to study the aberrance and investigate any relationship with 
the abnormal deaths, and measures may be developed to circumvent the issues and facilitate the 
healthy development and metabolism of cloned piglets.  
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Figure 6: Pie charts depicting the functional classification on basis of molecular function of 
proteins up-regulated (A) and down-regulated (B) in cloned dead piglets as compared to cloned 
live piglets 
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Figure 7: Differentially expressed proteins in cloned piglets as compared to normal piglets in 
glycolysis, and their role in the process. The grayed out proteins are differentially expressed in 
cloned piglets. 
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Figure 8: Differentially expressed proteins in cloned piglets as compared to normal piglets in 
TCA cycle, and their role in the process. The grayed out proteins are differentially expressed in 
cloned piglets. 
 
4.4 Proteins related to heart development 
The study found proteins specific for signaling pathways for heart development among the 
differentially expressed proteins in cloned piglets. These proteins exert complex functions in 
signaling pathways include Wnt signaling, TGF-β signaling and Notch signaling and their 
deranged expression levels may reduce in abnormal deaths. Signaling proteins control a number 
of other proteins involved in vital roles of cell development and regulation. A depiction of such 
proteins found to be grossly down-regulated in SCNT clones, and the large number of proteins 
they control and affect, is shown in Figure 9.  In addition, we found at least 14 differentially 
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expressed proteins in mammalian and 10 in S. scrofa that are related to heart development and 
muscle contraction. These include different isoforms of actin, myosin, troponin, tropomyosin, 
actinin, titin, nebulin, keratin, profilin, calsarcin, lamin, collagen, sarcalumenin and cofilin. 
Among these proteins, some like actinin, myosin, lamin and titin have been frequently detected 
among the heart samples, indicating that faulty functioning of the heart might be a cause of 
abnormal deaths in cloned animals. Therefore, these proteins can be used as internal markers of a 
successful proteome identification process during batch analysis. As expected, these proteins 
were represented in our results.  
 
Figure 9: Differentially expressed proteins involved in signaling pathways grossly down-
regulated in SCNT clones, and the related proteins they affect. The images were drawn using 
Cytoscape 3.0.1 
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147 differentially expressed proteins were found among normal and cloned piglets. The proteins 
belonged to a variety of biological processes and signaling pathways. However, these proteins 
were also inter-connected via a number of pathways. Hence, the up- or down-regulation of a 
protein could affect other pathways in which the protein is not directly involved. Seven 
differentially expressed proteins that were highly abundant were considered and their 
interactions analyzed. The proteins were succinate dehydrogenase and pyruvate dehydrogenase 
(involved in basal metabolism), adenosylhomocysteinase (involved in control of methylations), 
electron transfer flavoprotein (involved in cellular respiration), cationic amino acid transporter 2 
(plays regulatory role in activation of macrophages), superoxide dismutase 2 (involved in 
removal of toxic superoxide anion radicals from the cell) and dystrophin (involved in structural 
integrity and signaling events). The inter-relationship between these proteins is depicted in 
Figure 10. 
Another abundant protein with gross differential expression was 40S ribosomal protein SA 
(rpsA). This protein plays a pivotal role in the adhesion of cell to the basement membrane and in 
the consequent activation of signaling pathways. This protein also plays a role in cell fate 
determination and morphogenesis. The differential expression of this protein points towards a 
probable cause of aberrant and/or incomplete development and often subsequent death of SCNT 
clones. rpsA also affects the function of many other proteins involved in various pathways. A 
depiction of the number of pathways affected by rpsA is given in Figure 11.  
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Figure 10: Interconnection between differentially expressed proteins involved in different 
biological processes. The images were drawn using Cytoscape 3.0.1 
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Figure 11: Number of signaling proteins inter-connected to rpsA, which is majorly differentially 
regulated in cloned piglets. The images were drawn using Cytoscape 3.0.1 
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Chapter 5 
CONCLUSION 
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This study provides the first exhaustive analysis of global proteins in heart of pigs. To the best of 
my knowledge, no previous study has performed global profiling of heart proteins and hence, the 
results of this study may be used as a reference map for future proteomic studies. Furthermore, 
the study showed that basal metabolism is grossly abnormal and several proteins related to heart 
organogenesis and functionality were either up- or down-regulated in the cloned piglets. These 
abnormalities were more pronounced in the dead SCNT clones and thus, may imply that the 
heart of SCNT clones is developmentally and functionally insufficient and hence, may be the 
cause of high peri-natal death. Future studies should decipher the mechanism of these 
abnormalities and novel ways to circumvent these abnormalities to increase the SCNT 
efficiency. 
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